Saffron Walden, United Kingdom

David Hardick



 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Stretham, GB (2015 - 2016)
  • Saffron Walden, GB (2020 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovator David Hardick: Advancements in Vasopressin Receptor Antagonists

Introduction

David Hardick, an accomplished inventor based in Saffron Walden, Great Britain, has made significant contributions to the field of pharmacology with a focus on vasopressin receptor antagonists. With a portfolio of four patents, his work exemplifies innovation in drug development aimed at addressing various health issues.

Latest Patents

Among David Hardick's latest patents are compounds designed to antagonize vasopressin receptors, particularly the V1a receptor. These compounds are crucial in the development of products and methods related to their synthesis and use. The patents include detailed descriptions of the chemical structures and potential applications, specifically highlighting how these compounds can be tailored as pharmaceutically acceptable isomers, racemates, hydrates, solvates, isotopes, or salts. His work not only furthers understanding in the therapeutic area but also illustrates the meticulous research behind drug formulation.

Career Highlights

David has had a notable career, contributing his expertise to prominent companies in the pharmaceutical sector, including Blackthorn Therapeutics, Inc. and Neumora Therapeutics, Inc. His positions within these innovative organizations have provided him with the platform to develop his patented compounds, focusing on enhancing therapeutic options for patients.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Robert M. Jones and Mariangela Urbano. These partnerships reflect the collaborative spirit inherent in the research and development phases of pharmaceutical innovations, often leading to groundbreaking advancements in medical science.

Conclusion

In conclusion, David Hardick stands out as an innovative inventor whose work on vasopressin receptor antagonists is paving the way for new therapeutic possibilities. With a strong background in pharmaceutical research, his contributions continue to resonate within the industry, particularly in the pursuit of effective medical treatments. His journey of innovation and collaboration undoubtedly places him among the notable figures in the realm of modern invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…